Effects of Green Synthesised Silver Nanoparticles (ST06-AgNPs) Using Curcumin Derivative (ST06) on Human Cervical Cancer Cells (HeLa) in Vitro and EAC Tumor Bearing Mice Models

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2019 Aug 15

PMID 31409988

Citations 21

Authors

Kalaimathi Murugesan

Jinsha Koroth

Padma Priya Srinivasan

Amrita Singh

Sanjana Mukundan

Subhas S Karki

Bibha Choudhary

Chhitar M Gupta

Affiliations

Soon will be listed here.

Abstract

Background: In recent years, green synthesized silver nanoparticles have been increasingly investigated for their anti-cancer potential. In the present study, we aimed at the biosynthesis of silver nanoparticles (AgNPs) using a curcumin derivative, ST06. Although, the individual efficacies of silver nanoparticles or curcumin derivatives have been studied previously, the synergistic cytotoxic effects of curcumin derivative and silver nanoparticles in a single nanoparticulate formulation have not been studied earlier specifically on animal models. This makes this study novel compared to the earlier synthesized curcumin derivative or silver nanoparticles studies. The aim of the study was to synthesize ST06 coated silver nanoparticles (ST06-AgNPs) using ST06 as both reducing and coating agent.

Methods: The synthesized nanoparticles AgNPs and ST06-AgNPs were characterised for the particle size distribution, morphology, optical properties and surface charge by using UV-visible spectroscopy, dynamic light scattering (DLS) and transmission electron microscopy (TEM). Elemental composition and structural properties were studied by energy dispersive X-ray spectroscopy (EDX) and X-ray diffraction spectroscopy (XRD). The presence of ST06 as capping agent was demonstrated by Fourier transform infrared spectroscopy (FTIR).

Results: The synthesized nanoparticles (ST06-AgNPs) were spherical and had a size distribution in the range of 50-100 nm. UV-Vis spectroscopy displayed a specific silver plasmon peak at 410 nm. The in vitro cytotoxicity effects of ST06 and ST06-AgNPs, as assessed by MTT assay, showed significant growth inhibition of human cervical cancer cell line (HeLa). In addition, studies carried out in EAC tumor-induced mouse model (Ehrlich Ascites carcinoma) using ST06-AgNPs, revealed that treatment of the animals with these nanoparticles resulted in a significant reduction in the tumor growth, compared to the control group animals.

Conclusion: In conclusion, green synthesized ST06-AgNPs exhibited superior anti-tumor efficacy than the free ST06 or AgNPs with no acute toxicity under both in vitro and in vivo conditions. The tumor suppression is associated with the intrinsic apoptotic pathway. Together, the results of this study suggest that ST06-AgNPs could be considered as a potential option for the treatment of solid tumors.

Citing Articles

Metal-based nanoparticle in cancer treatment: lessons learned and challenges.

Hheidari A, Mohammadi J, Ghodousi M, Mahmoodi M, Ebrahimi S, Pishbin E Front Bioeng Biotechnol. 2024; 12:1436297.

PMID: 39055339 PMC: 11269265. DOI: 10.3389/fbioe.2024.1436297.

Updates on Biogenic Metallic and Metal Oxide Nanoparticles: Therapy, Drug Delivery and Cytotoxicity.

Nikolova M, Joshi P, Chavali M Pharmaceutics. 2023; 15(6).

PMID: 37376098 PMC: 10301310. DOI: 10.3390/pharmaceutics15061650.

A technical note on emerging combination approach involved in the onconanotherapeutics.

Iqubal M, Kaur H, Md S, Alhakamy N, Iqubal A, Ali J Drug Deliv. 2022; 29(1):3197-3212.

PMID: 36226570 PMC: 9578464. DOI: 10.1080/10717544.2022.2132018.

Critical Review on Nutritional, Bioactive, and Medicinal Potential of Spices and Herbs and Their Application in Food Fortification and Nanotechnology.

Mandal D, Sarkar T, Chakraborty R Appl Biochem Biotechnol. 2022; 195(2):1319-1513.

PMID: 36219334 PMC: 9551254. DOI: 10.1007/s12010-022-04132-y.

ST08 Altered NF-κB Pathway in Breast Cancer Cells as Revealed by miRNA-mRNA Analysis and Enhanced the Effect of Cisplatin on Tumour Reduction in EAC Mouse Model.

Nirgude S, Desai S, Mahadeva R, Ravindran F, Choudhary B Front Oncol. 2022; 12:835027.

PMID: 35615145 PMC: 9125255. DOI: 10.3389/fonc.2022.835027.

References

Haupt S, Berger M, Goldberg Z, Haupt Y . Apoptosis - the p53 network. J Cell Sci. 2003; 116(Pt 20):4077-85. DOI: 10.1242/jcs.00739. View

Garcea G, Jones D, Singh R, Dennison A, Farmer P, Sharma R . Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer. 2004; 90(5):1011-5. PMC: 2409622. DOI: 10.1038/sj.bjc.6601623. View

Gafner S, Lee S, Cuendet M, Barthelemy S, Vergnes L, Labidalle S . Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Phytochemistry. 2004; 65(21):2849-59. DOI: 10.1016/j.phytochem.2004.08.008. View

Yang K, Lin L, Tseng T, Wang S, Tsai T . Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 853(1-2):183-9. DOI: 10.1016/j.jchromb.2007.03.010. View

Hsin Y, Chen C, Huang S, Shih T, Lai P, Chueh P . The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol Lett. 2008; 179(3):130-9. DOI: 10.1016/j.toxlet.2008.04.015. View

Asharani P, Mun G, Hande M, Valiyaveettil S . Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009; 3(2):279-90. DOI: 10.1021/nn800596w. View

Fuchs J, Pandit B, Bhasin D, Etter J, Regan N, Abdelhamid D . Structure-activity relationship studies of curcumin analogues. Bioorg Med Chem Lett. 2009; 19(7):2065-9. DOI: 10.1016/j.bmcl.2009.01.104. View

Wong K, Cheung S, Huang L, Niu J, Tao C, Ho C . Further evidence of the anti-inflammatory effects of silver nanoparticles. ChemMedChem. 2009; 4(7):1129-35. DOI: 10.1002/cmdc.200900049. View

Kalishwaralal K, Banumathi E, Pandian S, Deepak V, Muniyandi J, Eom S . Silver nanoparticles inhibit VEGF induced cell proliferation and migration in bovine retinal endothelial cells. Colloids Surf B Biointerfaces. 2009; 73(1):51-7. DOI: 10.1016/j.colsurfb.2009.04.025. View

10.

Gurunathan S, Lee K, Kalishwaralal K, Sheikpranbabu S, Vaidyanathan R, Eom S . Antiangiogenic properties of silver nanoparticles. Biomaterials. 2009; 30(31):6341-50. DOI: 10.1016/j.biomaterials.2009.08.008. View

11.

Shehzad A, Wahid F, Lee Y . Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim). 2010; 343(9):489-99. DOI: 10.1002/ardp.200900319. View

12.

Sriram M, Kanth S, Kalishwaralal K, Gurunathan S . Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model. Int J Nanomedicine. 2010; 5:753-62. PMC: 2962271. DOI: 10.2147/IJN.S11727. View

13.

Sanpui P, Chattopadhyay A, Ghosh S . Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier. ACS Appl Mater Interfaces. 2011; 3(2):218-28. DOI: 10.1021/am100840c. View

14.

Varaprasad K, Vimala K, Ravindra S, Narayana Reddy N, Reddy G, Mohana Raju K . Fabrication of silver nanocomposite films impregnated with curcumin for superior antibacterial applications. J Mater Sci Mater Med. 2011; 22(8):1863-72. DOI: 10.1007/s10856-011-4369-5. View

15.

Lara H, Garza-Trevino E, Ixtepan-Turrent L, Singh D . Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds. J Nanobiotechnology. 2011; 9:30. PMC: 3199605. DOI: 10.1186/1477-3155-9-30. View

16.

Das S, Das U, Varela-Ramirez A, Lema C, Aguilera R, Balzarini J . Bis[3,5-bis(benzylidene)-4-oxo-1-piperidinyl]amides: a novel class of potent cytotoxins. ChemMedChem. 2011; 6(10):1892-9. PMC: 3344817. DOI: 10.1002/cmdc.201100199. View

17.

Wei X, Du Z, Zheng X, Cui X, Conney A, Zhang K . Synthesis and evaluation of curcumin-related compounds for anticancer activity. Eur J Med Chem. 2012; 53:235-45. DOI: 10.1016/j.ejmech.2012.04.005. View

18.

Kheybari S, Samadi N, Hosseini S, Fazeli A, Fazeli M . Synthesis and antimicrobial effects of silver nanoparticles produced by chemical reduction method. Daru. 2012; 18(3):168-72. PMC: 3304363. View

19.

Doane T, Burda C . Nanoparticle mediated non-covalent drug delivery. Adv Drug Deliv Rev. 2012; 65(5):607-21. PMC: 3747039. DOI: 10.1016/j.addr.2012.05.012. View

20.

Kim S, Jung J, Lamsal K, Kim Y, Min J, Lee Y . Antifungal Effects of Silver Nanoparticles (AgNPs) against Various Plant Pathogenic Fungi. Mycobiology. 2012; 40(1):53-8. PMC: 3385153. DOI: 10.5941/MYCO.2012.40.1.053. View